MXPA02012819A - Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias. - Google Patents

Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias.

Info

Publication number
MXPA02012819A
MXPA02012819A MXPA02012819A MXPA02012819A MXPA02012819A MX PA02012819 A MXPA02012819 A MX PA02012819A MX PA02012819 A MXPA02012819 A MX PA02012819A MX PA02012819 A MXPA02012819 A MX PA02012819A MX PA02012819 A MXPA02012819 A MX PA02012819A
Authority
MX
Mexico
Prior art keywords
intravaginal
fungal
viral
bacterial
parasitic infections
Prior art date
Application number
MXPA02012819A
Other languages
English (en)
Inventor
Donald C Harrison
Original Assignee
Umd Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umd Inc filed Critical Umd Inc
Publication of MXPA02012819A publication Critical patent/MXPA02012819A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
MXPA02012819A 2000-07-11 2001-06-25 Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias. MXPA02012819A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/613,441 US6416779B1 (en) 1997-06-11 2000-07-11 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
PCT/US2001/041128 WO2002003896A1 (en) 2000-07-11 2001-06-25 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections

Publications (1)

Publication Number Publication Date
MXPA02012819A true MXPA02012819A (es) 2003-09-22

Family

ID=24457329

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012819A MXPA02012819A (es) 2000-07-11 2001-06-25 Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias.

Country Status (12)

Country Link
US (1) US6416779B1 (es)
EP (1) EP1301150A4 (es)
JP (1) JP2004508296A (es)
CN (1) CN1306919C (es)
AU (2) AU8128701A (es)
BR (1) BR0112571A (es)
CA (1) CA2416050A1 (es)
HK (1) HK1054676A1 (es)
IL (2) IL153719A0 (es)
MX (1) MXPA02012819A (es)
NZ (1) NZ524047A (es)
WO (1) WO2002003896A1 (es)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043071A1 (en) * 2002-06-21 2004-03-04 Pauletti Giovanni M. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US20030064103A1 (en) * 2001-05-01 2003-04-03 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US20060172007A1 (en) * 2001-05-01 2006-08-03 Nawaz Ahmad Compositions and methods for reducing vaginal pH
US20030017207A1 (en) * 2001-05-01 2003-01-23 Lin Shun Y. Compositions and methods for treating vulvovaginitis and vaginosis
US7267670B2 (en) * 2001-08-30 2007-09-11 Mulholland S Grant Reinforced urethral suppository
US7022333B2 (en) * 2001-10-02 2006-04-04 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US7026354B2 (en) * 2001-10-02 2006-04-11 Kimberly-Clark Worldwide, Inc. Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
US20030135173A1 (en) * 2001-10-02 2003-07-17 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production in absorbent articles using aromatic compositions
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20060105008A1 (en) * 2002-03-28 2006-05-18 Nawaz Ahmad Compositions and methods for reducing vaginal pH
MXPA04011584A (es) * 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US20040126369A1 (en) * 2002-12-30 2004-07-01 Richard Payne Delivery of peroxide-generating enzymes to the vaginal tract
EP1620060B1 (en) * 2003-04-29 2010-03-24 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
US8399013B2 (en) * 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
EP1500394A1 (en) * 2003-07-22 2005-01-26 Polichem S.A. Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
MY144021A (en) 2003-09-19 2011-07-29 Drugtech Corp Pharmaceutical delivery system
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050113730A1 (en) * 2003-11-24 2005-05-26 Sca Hygiene Products Ab Absorbent Article Containing A Skin Care Product
SE0303123D0 (sv) * 2003-11-24 2003-11-24 Sca Hygiene Prod Ab Absorberande alster med hudvårdande medel
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
US7276486B2 (en) * 2004-03-15 2007-10-02 Kimberly-Clark Worldwide, Inc. Compositions for vaginal treatment
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
SI2422789T1 (en) * 2004-05-19 2018-07-31 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center An injectable composition comprising sodium deoxycholate
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006024138A1 (en) * 2004-08-30 2006-03-09 Taro Pharmaceutical Industries Ltd. A thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
US20060100566A1 (en) * 2004-11-05 2006-05-11 Women's Medical Research Group, Llc Apparatus and method for the treatment of dysmenorrhea
US20060137684A1 (en) * 2004-12-01 2006-06-29 Celeste Evans Compositions and methods of treating irritation and kit therefor
US8062658B2 (en) 2004-12-14 2011-11-22 Poly-Med, Inc. Multicomponent bioactive intravaginal ring
US7744556B2 (en) * 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7919453B2 (en) * 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7993667B2 (en) * 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7527614B2 (en) * 2005-03-25 2009-05-05 Kimberly-Clark Worldwide, Inc. Protective tube for a medicated tampon
US9295289B2 (en) * 2005-04-01 2016-03-29 Leslie Jane James Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
US7708726B2 (en) * 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
CN100446774C (zh) * 2005-05-31 2008-12-31 黑龙江龙桂制药有限公司 盐酸克林霉素阴道泡腾片及其制备方法
US20070016156A1 (en) * 2005-07-15 2007-01-18 The Procter & Gamble Company Absorbent tampon comprising a visually distinct withdrawal member
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
US20070141118A1 (en) * 2005-12-15 2007-06-21 Damico Joyce A Layered dosage form for a medicated tampon assembly
CA2635986A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
KR20080083190A (ko) * 2006-01-05 2008-09-16 드러그테크 코포레이션 외음질 표면에 생체접착을 위한 약물 전달 시스템
EP2944382A1 (en) 2006-04-26 2015-11-18 Micell Technologies, Inc. Coatings containing multiple drugs
JP2009536926A (ja) 2006-05-12 2009-10-22 ファルマコン−フォルシュンク ウント ベラツンク ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗真菌剤を含む複合製剤の使用
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
US7824383B2 (en) * 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
CA2657533A1 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
US20080077106A1 (en) * 2006-09-22 2008-03-27 Ryo Minoguchi Tampon having an asymmetric insertion end and a finger pocket
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
JP5336382B2 (ja) 2006-10-23 2013-11-06 ミセル テクノロジーズ、インコーポレイテッド コーティングの間に基板を荷電するためのホルダー
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CA2688314C (en) * 2007-05-25 2013-12-03 Micell Technologies, Inc. Polymer films for medical device coating
US8747346B2 (en) * 2007-06-01 2014-06-10 Martin Hochberg Hemostatic agent applicator for survical procedures
DK3441054T3 (da) * 2007-11-05 2020-11-09 Abigo Medical Ab Indretning til behandling af vaginal svampeinfektion
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
JP5608160B2 (ja) 2008-04-17 2014-10-15 ミセル テクノロジーズ、インコーポレイテッド 生体吸収性の層を有するステント
US9034365B2 (en) * 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
WO2011009096A1 (en) 2009-07-16 2011-01-20 Micell Technologies, Inc. Drug delivery medical device
EP2313122B1 (en) 2008-07-17 2019-03-06 Micell Technologies, Inc. Drug delivery medical device
US8263115B2 (en) * 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
ZA200908494B (en) * 2008-11-30 2010-12-29 Univ Of The Witwatersrand A controlled release intravaginal polymeric pharmaceutical dosage form
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
ITFI20090011A1 (it) * 2009-01-22 2010-07-23 Enrica Badiani Dispositivo intravaginale
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2411083A4 (en) 2009-03-23 2013-11-13 Micell Technologies Inc MEDICAL DEVICE FOR DELIVERY OF MEDICAMENT
WO2010120552A2 (en) 2009-04-01 2010-10-21 Micell Technologies, Inc. Coated stents
US8691235B2 (en) * 2009-04-03 2014-04-08 Poly-Med, Inc. Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
EP2243482A1 (en) * 2009-04-20 2010-10-27 Polichem SA Use of nifuratel to treat infections caused by atopobium species
CN109394689A (zh) 2009-05-05 2019-03-01 德州大学系统董事会 挥发性麻醉剂的新型制剂及其用于减轻炎症的使用方法
WO2011068874A2 (en) 2009-12-01 2011-06-09 University Of South Florida Drug delivery device for ovarian cancer
US11369498B2 (en) 2010-02-02 2022-06-28 MT Acquisition Holdings LLC Stent and stent delivery system with improved deliverability
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
EP2560576B1 (en) 2010-04-22 2018-07-18 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
US20130172853A1 (en) 2010-07-16 2013-07-04 Micell Technologies, Inc. Drug delivery medical device
WO2012092990A2 (de) 2011-01-05 2012-07-12 Udo Wenske Medizinprodukt zur verbesserung der konzeptionsfähigkeit eines säugetiers
WO2012112940A1 (en) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8476221B2 (en) 2011-03-18 2013-07-02 Halimed Pharmaceuticals, Inc. Methods and compositions for the treatment of metabolic disorders
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
WO2012158779A1 (en) * 2011-05-17 2012-11-22 Reprotect, Inc. Reusable intravaginal delivery device, system, and method
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
KR20140074281A (ko) * 2011-07-20 2014-06-17 패트릭 에프. 카이저 약물 전달용 질내 장치
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
ITRM20120404A1 (it) * 2012-08-09 2014-02-10 Univ Roma Uso del kgf nel trattamento di disturbi della menopausa
JP6330024B2 (ja) 2013-03-12 2018-05-23 マイセル・テクノロジーズ，インコーポレイテッド 生体吸収性バイオメディカルインプラント
US10272606B2 (en) 2013-05-15 2019-04-30 Micell Technologies, Inc. Bioabsorbable biomedical implants
GB2519055A (en) * 2013-08-01 2015-04-15 Calla Lily Personal Care Ltd Drug delivery device
DE102014012206A1 (de) * 2014-05-26 2015-11-26 Jean-Jacques Becciolini Arzneimittelträger zum Behandeln und Vorbeugen von krankhaften Zuständen im urogenitalen Raum
US10004918B2 (en) * 2014-07-03 2018-06-26 Gregg Alan Klang LED based vaginal light therapy device
CN104546267B (zh) * 2015-01-13 2017-01-04 安徽农业大学 一种犬用宫外节育装置及其节育方法
MA41629A (fr) 2015-03-04 2018-01-09 Center For Human Reproduction Compositions et méthodes d'utilisation de l'hormone anti-müllérienne pour le traitement de l'infertilité
BR112018013575A2 (pt) * 2015-12-30 2019-02-19 V-Veil-Shop Ltd. malha morfo-anatômica flexível
US20210330599A1 (en) 2016-08-01 2021-10-28 University Of Rochester Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
AU201617347S (en) * 2016-12-23 2017-01-23 Jurox Pty Ltd intravaginal device
USD848630S1 (en) * 2017-01-17 2019-05-14 Gregg A. Klang Vaginal light treatment device
US11124547B2 (en) * 2017-05-11 2021-09-21 The Lundquist Institute For Biomedical Innovation Antimicrobial type-II bacteriocins
EP3668464A4 (en) * 2017-08-15 2021-08-18 Binyarco LLC METHOD AND DEVICE FOR PACKAGING A BODY CAVITY AND DISPENSING A DRUG TO A PERSON
CN111246824B (zh) * 2017-09-18 2022-03-22 德瑞克·席安 装配阴道治疗装置的方法和系统
US20220040136A1 (en) 2018-10-09 2022-02-10 University Of Rochester Treatment of vulvovaginal disorders
US11382799B2 (en) 2018-11-26 2022-07-12 Bluegrass Farmaceuticals, LLC Tampon with intravaginal cannabinoid delivery device
CN109771804A (zh) * 2019-03-18 2019-05-21 郑岩 一种多种高分子材料制作的阴道霉菌治疗装置
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
EP4277599A1 (en) 2021-01-14 2023-11-22 Herphoric, Inc. A delivery system for a pharmaceutical, holistic or medicinal component
CN112999452B (zh) * 2021-04-23 2023-02-28 杨璐 一种妇产科用洗剂注射装置

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852155A (en) 1971-09-02 1974-12-03 R Moore Cryopreservation of equine cell cultures
US3885564A (en) * 1972-07-24 1975-05-27 Harvey H Groves Vaginal medicator
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US4073743A (en) 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4016270A (en) 1975-10-31 1977-04-05 Alza Corporation Method for treating dysmenorrhea with a uterine therapeutic system
US4250166A (en) 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
US4420474A (en) * 1979-10-15 1983-12-13 E. R. Squibb & Sons, Inc. Synergistic antifungal compositions
US4318405A (en) 1980-07-24 1982-03-09 Sneider Vincent R Tampon and drug delivery device
US4405323A (en) 1981-09-08 1983-09-20 Sidney Auerbach Sanitary napkin
US4863725A (en) 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4540581A (en) 1984-01-31 1985-09-10 Bristol-Myers Company Topical nonsteroidal anti-inflammatory compositions and uses
US4553972A (en) * 1983-05-20 1985-11-19 Syntex (U.S.A.) Inc. Disposable intravaginal contraceptive devices releasing 1-substituted imidazoles
US4560549A (en) 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US4983392A (en) 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
DE3486448T2 (de) 1983-11-14 1997-10-09 Columbia Lab Inc Bioadhäsive Mittel
US5231112A (en) * 1984-04-12 1993-07-27 The Liposome Company, Inc. Compositions containing tris salt of cholesterol hemisuccinate and antifungal
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
JPS6160620A (ja) 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
ATE68686T1 (de) 1985-10-31 1991-11-15 Kv Pharm Co System zum freigeben von stoffen in der vagina.
DE3875762T2 (de) 1987-03-17 1993-05-13 Akzo Nv Adjuvanzienmischung.
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
CA1341245C (en) 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
DE3865675D1 (de) * 1988-07-28 1991-11-21 Uriach & Cia Sa J 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazol.
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
WO1990007325A1 (en) * 1988-12-30 1990-07-12 Edko Trading And Representation Company Limited A pessary containing antibacterial drugs
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
IT1230157B (it) 1989-06-16 1991-10-14 Lisapharma Spa Uso di sucralfato gel umido per il trattamento di ulcere del derma e come veicolo di farmaci ad attivita' topica
DE3928677C2 (de) 1989-08-30 1998-05-14 Kimberly Clark Gmbh Tampon für medizinische oder hygienische Zwecke sowie Verfahren zu seiner Herstellung
FR2665357B1 (fr) 1990-07-31 1995-03-31 Aiache Jean Marc Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
US5275820A (en) 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
JPH0735335B2 (ja) * 1991-02-28 1995-04-19 五十嵐 正雄 子宮内膜症の治療薬
AU1797592A (en) * 1991-04-12 1992-11-17 Upjohn Company, The Vaginal drug delivery device
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5393528A (en) 1992-05-07 1995-02-28 Staab; Robert J. Dissolvable device for contraception or delivery of medication
US5273521A (en) 1992-08-26 1993-12-28 Peiler Frances K Tampon applicator for delivery of a medicament
US5458884A (en) * 1992-09-10 1995-10-17 Britton; Peter Bioerodible device for administering active ingredients
DE69332954D1 (de) 1992-10-21 2003-06-12 Gynetech Lab Inc Abgabesystem bestehend aus einem vaginaschwamm
US5330761A (en) 1993-01-29 1994-07-19 Edward Mendell Co. Inc. Bioadhesive tablet for non-systemic use products
GB9318641D0 (en) * 1993-09-08 1993-10-27 Edko Trading Representation Compositions
TW438601B (en) * 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
US5742525A (en) * 1995-01-10 1998-04-21 Ye; Yuancai Method for eliminating the fluctuation and drift of spectral line intensities
US5741525A (en) * 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
GB9522403D0 (en) 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5827543A (en) * 1995-12-07 1998-10-27 The Procter & Gamble Company Methods and compositions for the prevention and treatment of urogenital disorders
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea

Also Published As

Publication number Publication date
US6416779B1 (en) 2002-07-09
JP2004508296A (ja) 2004-03-18
NZ524047A (en) 2005-08-26
CA2416050A1 (en) 2002-01-17
AU2001281287B2 (en) 2006-10-19
IL153719A0 (en) 2003-07-06
AU8128701A (en) 2002-01-21
BR0112571A (pt) 2003-05-27
CN1306919C (zh) 2007-03-28
EP1301150A4 (en) 2004-08-11
AU2001281287B8 (en) 2006-12-07
EP1301150A1 (en) 2003-04-16
HK1054676A1 (zh) 2003-12-12
IL153719A (en) 2009-12-24
CN1592600A (zh) 2005-03-09
WO2002003896A1 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
MXPA02012819A (es) Dispositivo y metodo para tratamiento intravaginal o transvaginal de infecciones fungales, bacterianas, virales o parasitarias.
WO2002015519A3 (en) Method and system for wireless voice channel/data channel integration
AU2001261306A1 (en) High mobility heterojunction transistor and method
AU2001261752A1 (en) Compositions and methods for treating otic, ophthalmic and nasal infections
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
GB0101577D0 (en) Compounds
GB2381974B (en) Method and device for active impedance matching
AU2002232550A1 (en) Device and method for treatment of surface infections with nitric oxide
MXPA02005735A (es) Tratamieno de enzimas para infeccion.
EP1663959A4 (en) NEW AMIDINE COMPOUNDS FOR THE TREATMENT OF MICROBIAL INFECTIONS
MXPA03004401A (es) Metodos y dispositivos para tratar problemas de tartamudez.
AUPR839001A0 (en) Dosage form, device and methods of treatment
AU2002232558A1 (en) Compounds, compositions and methods for treatment of parasitic infections
AU2002326699A1 (en) Cryptographic method and system for restricting mobility in radio networks.
AU2003279526A1 (en) Identifying and treating vaginal infections
MXPA03003796A (es) Procedimiento y dispositivos de aplicacion por vertido.
WO2001040473A3 (en) Pseudomonas aeruginosa antigens
AU2002239485A1 (en) Methods for improved diagnosis and treatment of mycobacterial infections
AU2002353774A1 (en) Products and methods for treating microbial infections
AU2002365083A8 (en) Composition and method to treat viral bacterial and parasitic infections and infestations
MXPA03005526A (es) Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales.
AU2002227240A1 (en) Treatment and method using loratadine and montelukast
ZA200102636B (en) Method of treating a parasitic infection.
WO2002024223A3 (en) Prevention and treatment of streptococcal and staphylococcal infection
AU3229001A (en) State machine, semiconductor device using state machine, and method of design thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal